Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

227
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
227

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Freeze-Drying as a Novel Concentrating Method for Wastewater Detection of SARS-CoV-2.

medRxiv : the preprint server for health sciences·2026
Same author

Opioid Use After Screw Fixation of Slipped Capital Femoral Epiphysis.

JB & JS open access·2026
Same author

Volatile Organic Metabolites as Potential Biomarkers for Genitourinary Cancers: Review of the Applications and Detection Methods.

Metabolites·2025
Same author

Urinary volatile organic compounds (VOCs) based prostate cancer diagnosis via high-dimensional classification.

Journal of applied statistics·2024
Same author

Regression Trees With Fused Leaves.

Statistics in medicine·2024
Same author

Detection and Validation of Organic Metabolites in Urine for Clear Cell Renal Cell Carcinoma Diagnosis.

Metabolites·2024
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

677

Urinary Metabolome Study for Monitoring Prostate Cancer Recurrence Following Radical Prostatectomy.

Sabur Badmos1, Elizabeth Noriega Landa1, Kiana L Holbrook1

  • 1Department of Chemistry and Biochemistry, University of Texas at El Paso, El Paso, TX 79968, USA.

Cancers
|September 13, 2025
PubMed
Summary
This summary is machine-generated.

Urinary volatile organic compounds (VOCs) show promise for detecting prostate cancer (PCa) recurrence after surgery. This study identified over 100 VOCs that can differentiate PCa patients before and after radical prostatectomy (RP).

Keywords:
GC-MSPLS-DAVOCsbiochemical recurrencemetastatic recurrenceprostate cancer diagnosisradical prostatectomyurinary biomarkersvolatile organic compounds

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.2K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.1K

Related Experiment Videos

Last Updated: Jan 18, 2026

A New Technique for Treating Low-risk Prostate Cancer&#8212;Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

677
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.2K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.1K

Area of Science:

  • Urology
  • Oncology
  • Analytical Chemistry

Background:

  • Prostate cancer (PCa) is a common male malignancy.
  • Biochemical recurrence or metastasis affects 20-40% of patients post-radical prostatectomy (RP).
  • Early detection of PCa recurrence is crucial for effective patient management.

Purpose of the Study:

  • To explore the potential of urinary volatile organic compounds (VOCs) as biomarkers for PCa detection and monitoring.
  • To investigate the utility of VOCs in differentiating PCa patients before and after RP, including those with recurrence or metastasis.
  • To assess the application of metabolomics and machine learning in analyzing urinary VOCs for PCa diagnosis.

Main Methods:

  • Collected 165 urine samples from PCa-positive (pre- and post-RP) and PCa-negative individuals.
  • Categorized post-RP cohort into recovered healthy, biochemical recurrence, and recurrent metastasis groups.
  • Utilized stir bar sorptive extraction, gas chromatography-mass spectrometry, metabolomics, and machine learning for VOC analysis.

Main Results:

  • Identified over 100 potential VOCs capable of differentiating PCa patients.
  • Demonstrated the ability of VOCs to distinguish between pre-RP, post-RP, biochemical recurrence, and metastatic PCa.
  • Highlighted the potential of machine learning algorithms in analyzing VOC data for PCa stratification.

Conclusions:

  • Urinary VOCs show promise as biomarkers for differentiating PCa patients before and after RP.
  • These findings offer preliminary insights for developing post-treatment monitoring tools for PCa.
  • Further validation in larger, independent cohorts is necessary to confirm reproducibility and translational impact.